Advertisement
Canada markets closed
  • S&P/TSX

    24,162.83
    +194.33 (+0.81%)
     
  • S&P 500

    5,751.07
    +51.13 (+0.90%)
     
  • DOW

    42,352.75
    +341.16 (+0.81%)
     
  • CAD/USD

    0.7369
    -0.0010 (-0.13%)
     
  • CRUDE OIL

    74.45
    +0.74 (+1.00%)
     
  • Bitcoin CAD

    84,152.05
    -175.25 (-0.21%)
     
  • XRP CAD

    0.72
    -0.00 (-0.37%)
     
  • GOLD FUTURES

    2,673.20
    -6.00 (-0.22%)
     
  • RUSSELL 2000

    2,212.80
    +32.65 (+1.50%)
     
  • 10-Yr Bond

    3.9810
    +0.1310 (+3.40%)
     
  • NASDAQ

    18,137.85
    +219.38 (+1.22%)
     
  • VOLATILITY

    19.21
    -1.28 (-6.25%)
     
  • FTSE

    8,280.63
    -1.89 (-0.02%)
     
  • NIKKEI 225

    38,635.62
    +83.56 (+0.22%)
     
  • CAD/EUR

    0.6709
    +0.0024 (+0.36%)
     

Stocks in play: Stantec

Announced today that it has received approval from the Toronto Stock Exchange respecting the renewal of its Normal Course Issuer Bid. Pursuant to the NCIB documentation filed with the TSX, Stantec may purchase up to 5,538,309 common shares, representing approximately 5% of Stantec’s 110,766,187 issued and outstanding common shares as of November 2, 2022. The purchases may commence on November 16, 2022 and will terminate no later than November 15, 2023. StantecT.STN shares T.STN are trading up $1.87 at $67.59.

Read: